AU6094696A - Lead binding polypeptides and nucleotides coding therefor - Google Patents

Lead binding polypeptides and nucleotides coding therefor

Info

Publication number
AU6094696A
AU6094696A AU60946/96A AU6094696A AU6094696A AU 6094696 A AU6094696 A AU 6094696A AU 60946/96 A AU60946/96 A AU 60946/96A AU 6094696 A AU6094696 A AU 6094696A AU 6094696 A AU6094696 A AU 6094696A
Authority
AU
Australia
Prior art keywords
binding polypeptides
coding therefor
nucleotides coding
lead binding
lead
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60946/96A
Inventor
Osvaldo Lopez
Peter Joseph Murray
Dwane E. Wylie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioNebraska Inc
Original Assignee
BioNebraska Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNebraska Inc filed Critical BioNebraska Inc
Publication of AU6094696A publication Critical patent/AU6094696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU60946/96A 1995-06-05 1996-06-05 Lead binding polypeptides and nucleotides coding therefor Abandoned AU6094696A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US46279895A 1995-06-05 1995-06-05
US462798 1995-06-05
US54137395A 1995-10-10 1995-10-10
US541373 1995-10-10
PCT/US1996/009258 WO1996039518A1 (en) 1995-06-05 1996-06-05 Lead binding polypeptides and nucleotides coding therefor

Publications (1)

Publication Number Publication Date
AU6094696A true AU6094696A (en) 1996-12-24

Family

ID=27040456

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60946/96A Abandoned AU6094696A (en) 1995-06-05 1996-06-05 Lead binding polypeptides and nucleotides coding therefor

Country Status (2)

Country Link
AU (1) AU6094696A (en)
WO (1) WO1996039518A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
WO2000023082A1 (en) * 1998-10-19 2000-04-27 Yeda Research And Development Co. Ltd. Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
DE60123063T2 (en) * 2000-07-14 2007-03-01 Matsushita Electric Industrial Co., Ltd., Kadoma PEPTIDE FRUCTOSE AND A COMPLEX THEREOF WITH BINDING PROTEIN
CA2425000A1 (en) * 2000-10-20 2002-05-02 Inhibitex, Inc. Monoclonal antibodies to the map protein and method of use in treating or preventing infections
AU2002366640A1 (en) * 2001-12-11 2003-06-23 Expressive Constructs, Inc. Detection and removal of lead using lead-binding proteins
US20040052779A1 (en) * 2001-12-21 2004-03-18 Stinson Jeffrey R. Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US20050025763A1 (en) 2003-05-08 2005-02-03 Protein Design Laboratories, Inc. Therapeutic use of anti-CS1 antibodies
US7709610B2 (en) 2003-05-08 2010-05-04 Facet Biotech Corporation Therapeutic use of anti-CS1 antibodies
DK3006464T3 (en) 2011-06-10 2018-09-17 Canada Minister Nat Defence ANTIRICIN ANTIBODIES AND APPLICATIONS THEREOF
WO2014146575A1 (en) * 2013-03-19 2014-09-25 Beijing Shenogen Pharma Group Ltd. Antibodies and methods for treating estrogen receptor-associated diseases
US9403913B2 (en) 2014-09-16 2016-08-02 Ovascience, Inc. Anti-VASA antibodies, and methods of production and use thereof
UY36449A (en) 2014-12-19 2016-07-29 Novartis Ag COMPOSITIONS AND METHODS FOR ANTIBODIES DIRECTED TO BMP6
EP3471759A1 (en) 2016-06-15 2019-04-24 Novartis AG Methods for treating disease using inhibitors of bone morphogenetic protein 6 (bmp6)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2047717C (en) * 1989-03-14 2000-08-01 Fred W. Wagner Monoclonal antibodies for small moieties, methods therefor
US5679548A (en) * 1993-02-02 1997-10-21 The Scripps Research Institute Methods for producing polypeptide metal binding sites and compositions thereof
US5476939A (en) * 1993-12-30 1995-12-19 Abbott Laboratories Certain pyridyl and isoquinolyl carbinolamine derivatives

Also Published As

Publication number Publication date
WO1996039518A1 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
AU6241698A (en) Tace-like and matrilysin-like polypeptides
AU4370596A (en) Novel hedgehog-derived polypeptides
AU1116297A (en) Flk-1 binding protein
AU5923398A (en) Polynucleotides and polypeptides encoding receptors
AU8493498A (en) Screw cover and method
AU9164998A (en) Speech coding
AU5093796A (en) Human transcription factors and binding assays
AU6655894A (en) Phenylalanine-free protein and dna coding therefor
AU5685898A (en) Encoder and decoder
AU6094696A (en) Lead binding polypeptides and nucleotides coding therefor
AU4911096A (en) Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences
AU3702497A (en) Speech coding
AU5355996A (en) Human chemokine polypeptides
AU4394396A (en) Modified peptides
EP0739983A3 (en) Gene encoding lacto-n-biosidase
AU5384596A (en) Binding assembly
AU5989696A (en) Tcr vbeta5 peptides
AU3640397A (en) Ob protein binding protein
AU1101099A (en) Dna encoding a gababr2 polypeptide and uses thereof
AU6525094A (en) Improved sequencing gel
AU7520396A (en) Abl-interactor protein
AU6698496A (en) Metal-containing ribonucleotide polypeptides
AU5284296A (en) Immune-evading proteins
AU4586497A (en) Calcium-integrin binding protein
AU6153396A (en) E6ap-binding proteins